Topics
January/February 2016 | Special Focus: Inside The Treatment Pipeline
Reversing Retinal Ischemia
Using encapsulated cell technology, a novel device may some day be used to treat inadequate oxygenation associated with common diseases.
Logan Christensen, MD, and Jeffrey L. Olson, MD
May 1, 2026
Astellas Showcases New Geographic Atrophy Research at ARVO 2026
EyePoint Outlines Poster Presentations at the ARVO 2026
Oculis Showcases Pipeline Innovations Ahead of Key Data Readouts at ARVO 2026
April 30, 2026
Study Links Diabetic Retinopathy Severity to Higher Mortality Risk
April 2026 Insert
Editorially independent supported by Abbvie and Regenxbio
April 2026 Supplement
Editorially independent content supported with advertising by EyePoint
Free Print Subscription
Email Newsletter
Conference Calendar
